See also this year's filing and all EDGAR filings for this company.
PDF Report 0001042074_2014_Cymabay_Therapeutics_Inc.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001042074, Cymabay Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 32,239,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 3,000 |
| 3 | remainder_Assets | 258,000 |
| 4 | LiabilitiesCurrent | 9,488,000 |
| 5 | LiabilitiesNoncurrent | 9,000 |
| 6 | remainder_Liabilities | 4,407,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 4,871,000 |
| 9 | ResearchAndDevelopmentExpense | 4,525,000 |
| 10 | remainder_Expenses | 822,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 145,000 |
| 13 | remainder_ComprehensiveNetIncome | 2,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 32,500,000 |
| 1 | Liabilities | 13,904,000 |
| 2 | Expenses | 10,218,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 18,596,000 |
| 5 | NetIncome | -10,073,000 |
| 6 | ComprehensiveNetIncome | -10,072,000 |
| 7 | BaseVar | 28,384,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.31 |
| 9 | EconomicCapitalRatio | 2.54 |
Edgar->Model Mapping
Feature Distribution
